|Day Low/High||172.71 / 172.96|
|52 Wk Low/High||86.00 / 172.98|
European stocks rise on Friday, despite downbeat economic indicators for both the eurozone and the U.K.
Salix Pharmaceuticals, Ltd. (“Salix”) (NASDAQ: SLXP) and Cosmo Pharmaceuticals S.
Cramer likes Salix Pharmaceuticals but would like Lazard better at a 3% yield.
While the markets may still have further to fall, investors need to be ready with their shopping list of stocks to buy when the bottom finally comes, Cramer says.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Progenics Pharmaceuticals, Inc.
The shares of a number of companies that have announced or been speculated as targets in tax inversion deals are falling after the U.S. Treasury last night issued new regulations...
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a new lifetime high candidate
U.S. stock futures point lower; the U.S. clamps down on corporate inversions; Allergan in advanced talks to buy Salix; Facebook to unveil a new advertising platform.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) considers the Company’s August 29, 2014 resubmission of its supplemental New Drug Application (sNDA) for...
Here are some mid-cap stock picks that are worth a serious look.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that Cipla Limited has granted Salix exclusive rights under certain patent applications in the “Rifaximin Complexes” patent family controlled by ...
TheStreet highlights 3 stocks pushing the health care sector higher today.
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a momo momentum candidate
Some of the top 20 investors are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals, and are pressing Salix to consider selling itself.
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a strong on high relative volume candidate
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the FDA has granted tentative approval for UCERIS® (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate ...
Some investing ideas to profit from the tax inversion trend.
9/04/14: YY Inc. (YY) broke out above our consolidation level, triggering our entry price. Look for follow-through tomorrow.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced today that on August 29, 2014, it submitted its response to the March 7, 2011, Food and Drug Administration (FDA) Complete Response Letter (CRL) regarding the ...
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "perilous reversal" (up big yesterday but down big today) candidate
Stock index futures are dipping slightly Wednesday after the sharp run-up of the last two sessions and ahead of the July FOMC minutes.
U.S. stock futures are mixed; a report says Allergan approached Salix and at least one other company about a potential acquisition; Citigroup weighs sale of Japan unit.
It was reported that Allergan (AGN) approached the company and at least one other firm about a potential acquisition as it fights a hostile takeover from Valeant Pharmaceuticals (VRX).
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as an unusual social activity candidate
Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that it has received notice of the early termination of the waiting period for U.
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.